1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Artemisinin Combination Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Artemether+Lumefantrine 1.2.3 Artesunate+Amodiaquine 1.2.4 Dihydroartemisinin+Piperaquine 1.2.5 Artesunate+Mefloquine 1.2.6 Artesunate+Sulfadoxine-Pyrimethamine 1.2.7 Pyronaridine-Artesunate 1.2.8 Other 1.3 Market by Application 1.3.1 Global Artemisinin Combination Therapy Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Artemisinin Combination Therapy Market Perspective (2016-2027) 2.2 Artemisinin Combination Therapy Growth Trends by Regions 2.2.1 Artemisinin Combination Therapy Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Artemisinin Combination Therapy Historic Market Share by Regions (2016-2021) 2.2.3 Artemisinin Combination Therapy Forecasted Market Size by Regions (2022-2027) 2.3 Artemisinin Combination Therapy Industry Dynamic 2.3.1 Artemisinin Combination Therapy Market Trends 2.3.2 Artemisinin Combination Therapy Market Drivers 2.3.3 Artemisinin Combination Therapy Market Challenges 2.3.4 Artemisinin Combination Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Artemisinin Combination Therapy Players by Revenue 3.1.1 Global Top Artemisinin Combination Therapy Players by Revenue (2016-2021) 3.1.2 Global Artemisinin Combination Therapy Revenue Market Share by Players (2016-2021) 3.2 Global Artemisinin Combination Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Artemisinin Combination Therapy Revenue 3.4 Global Artemisinin Combination Therapy Market Concentration Ratio 3.4.1 Global Artemisinin Combination Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Artemisinin Combination Therapy Revenue in 2020 3.5 Artemisinin Combination Therapy Key Players Head office and Area Served 3.6 Key Players Artemisinin Combination Therapy Product Solution and Service 3.7 Date of Enter into Artemisinin Combination Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Artemisinin Combination Therapy Breakdown Data by Type 4.1 Global Artemisinin Combination Therapy Historic Market Size by Type (2016-2021) 4.2 Global Artemisinin Combination Therapy Forecasted Market Size by Type (2022-2027) 5 Artemisinin Combination Therapy Breakdown Data by Application 5.1 Global Artemisinin Combination Therapy Historic Market Size by Application (2016-2021) 5.2 Global Artemisinin Combination Therapy Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Artemisinin Combination Therapy Market Size (2016-2027) 6.2 North America Artemisinin Combination Therapy Market Size by Type 6.2.1 North America Artemisinin Combination Therapy Market Size by Type (2016-2021) 6.2.2 North America Artemisinin Combination Therapy Market Size by Type (2022-2027) 6.2.3 North America Artemisinin Combination Therapy Market Size by Type (2016-2027) 6.3 North America Artemisinin Combination Therapy Market Size by Application 6.3.1 North America Artemisinin Combination Therapy Market Size by Application (2016-2021) 6.3.2 North America Artemisinin Combination Therapy Market Size by Application (2022-2027) 6.3.3 North America Artemisinin Combination Therapy Market Size by Application (2016-2027) 6.4 North America Artemisinin Combination Therapy Market Size by Country 6.4.1 North America Artemisinin Combination Therapy Market Size by Country (2016-2021) 6.4.2 North America Artemisinin Combination Therapy Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Artemisinin Combination Therapy Market Size (2016-2027) 7.2 Europe Artemisinin Combination Therapy Market Size by Type 7.2.1 Europe Artemisinin Combination Therapy Market Size by Type (2016-2021) 7.2.2 Europe Artemisinin Combination Therapy Market Size by Type (2022-2027) 7.2.3 Europe Artemisinin Combination Therapy Market Size by Type (2016-2027) 7.3 Europe Artemisinin Combination Therapy Market Size by Application 7.3.1 Europe Artemisinin Combination Therapy Market Size by Application (2016-2021) 7.3.2 Europe Artemisinin Combination Therapy Market Size by Application (2022-2027) 7.3.3 Europe Artemisinin Combination Therapy Market Size by Application (2016-2027) 7.4 Europe Artemisinin Combination Therapy Market Size by Country 7.4.1 Europe Artemisinin Combination Therapy Market Size by Country (2016-2021) 7.4.2 Europe Artemisinin Combination Therapy Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Artemisinin Combination Therapy Market Size (2016-2027) 8.2 Asia-Pacific Artemisinin Combination Therapy Market Size by Type 8.2.1 Asia-Pacific Artemisinin Combination Therapy Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Artemisinin Combination Therapy Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Artemisinin Combination Therapy Market Size by Type (2016-2027) 8.3 Asia-Pacific Artemisinin Combination Therapy Market Size by Application 8.3.1 Asia-Pacific Artemisinin Combination Therapy Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Artemisinin Combination Therapy Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Artemisinin Combination Therapy Market Size by Application (2016-2027) 8.4 Asia-Pacific Artemisinin Combination Therapy Market Size by Region 8.4.1 Asia-Pacific Artemisinin Combination Therapy Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Artemisinin Combination Therapy Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Artemisinin Combination Therapy Market Size (2016-2027) 9.2 Latin America Artemisinin Combination Therapy Market Size by Type 9.2.1 Latin America Artemisinin Combination Therapy Market Size by Type (2016-2021) 9.2.2 Latin America Artemisinin Combination Therapy Market Size by Type (2022-2027) 9.2.3 Latin America Artemisinin Combination Therapy Market Size by Type (2016-2027) 9.3 Latin America Artemisinin Combination Therapy Market Size by Application 9.3.1 Latin America Artemisinin Combination Therapy Market Size by Application (2016-2021) 9.3.2 Latin America Artemisinin Combination Therapy Market Size by Application (2022-2027) 9.3.3 Latin America Artemisinin Combination Therapy Market Size by Application (2016-2027) 9.4 Latin America Artemisinin Combination Therapy Market Size by Country 9.4.1 Latin America Artemisinin Combination Therapy Market Size by Country (2016-2021) 9.4.2 Latin America Artemisinin Combination Therapy Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Artemisinin Combination Therapy Market Size (2016-2027) 10.2 Middle East & Africa Artemisinin Combination Therapy Market Size by Type 10.2.1 Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2016-2027) 10.3 Middle East & Africa Artemisinin Combination Therapy Market Size by Application 10.3.1 Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2016-2027) 10.4 Middle East & Africa Artemisinin Combination Therapy Market Size by Country 10.4.1 Middle East & Africa Artemisinin Combination Therapy Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Artemisinin Combination Therapy Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 KPC Pharmaceuticals 11.1.1 KPC Pharmaceuticals Company Details 11.1.2 KPC Pharmaceuticals Business Overview 11.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Introduction 11.1.4 KPC Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2016-2021) 11.1.5 KPC Pharmaceuticals Recent Development 11.2 Shanghai Fosun Pharmaceutical Industrial Development 11.2.1 Shanghai Fosun Pharmaceutical Industrial Development Company Details 11.2.2 Shanghai Fosun Pharmaceutical Industrial Development Business Overview 11.2.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Introduction 11.2.4 Shanghai Fosun Pharmaceutical Industrial Development Revenue in Artemisinin Combination Therapy Business (2016-2021) 11.2.5 Shanghai Fosun Pharmaceutical Industrial Development Recent Development 11.3 Sanofi 11.3.1 Sanofi Company Details 11.3.2 Sanofi Business Overview 11.3.3 Sanofi Artemisinin Combination Therapy Introduction 11.3.4 Sanofi Revenue in Artemisinin Combination Therapy Business (2016-2021) 11.3.5 Sanofi Recent Development 11.4 Desano Holdings 11.4.1 Desano Holdings Company Details 11.4.2 Desano Holdings Business Overview 11.4.3 Desano Holdings Artemisinin Combination Therapy Introduction 11.4.4 Desano Holdings Revenue in Artemisinin Combination Therapy Business (2016-2021) 11.4.5 Desano Holdings Recent Development 11.5 Calyx Chemicals and Pharmaceuticals 11.5.1 Calyx Chemicals and Pharmaceuticals Company Details 11.5.2 Calyx Chemicals and Pharmaceuticals Business Overview 11.5.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Introduction 11.5.4 Calyx Chemicals and Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2016-2021) 11.5.5 Calyx Chemicals and Pharmaceuticals Recent Development 11.6 Mylan 11.6.1 Mylan Company Details 11.6.2 Mylan Business Overview 11.6.3 Mylan Artemisinin Combination Therapy Introduction 11.6.4 Mylan Revenue in Artemisinin Combination Therapy Business (2016-2021) 11.6.5 Mylan Recent Development 11.7 Novartis 11.7.1 Novartis Company Details 11.7.2 Novartis Business Overview 11.7.3 Novartis Artemisinin Combination Therapy Introduction 11.7.4 Novartis Revenue in Artemisinin Combination Therapy Business (2016-2021) 11.7.5 Novartis Recent Development 11.8 Denk Pharma 11.8.1 Denk Pharma Company Details 11.8.2 Denk Pharma Business Overview 11.8.3 Denk Pharma Artemisinin Combination Therapy Introduction 11.8.4 Denk Pharma Revenue in Artemisinin Combination Therapy Business (2016-2021) 11.8.5 Denk Pharma Recent Development 11.9 Hovid Berhad 11.9.1 Hovid Berhad Company Details 11.9.2 Hovid Berhad Business Overview 11.9.3 Hovid Berhad Artemisinin Combination Therapy Introduction 11.9.4 Hovid Berhad Revenue in Artemisinin Combination Therapy Business (2016-2021) 11.9.5 Hovid Berhad Recent Development 11.10 Ipca Laboratories 11.10.1 Ipca Laboratories Company Details 11.10.2 Ipca Laboratories Business Overview 11.10.3 Ipca Laboratories Artemisinin Combination Therapy Introduction 11.10.4 Ipca Laboratories Revenue in Artemisinin Combination Therapy Business (2016-2021) 11.10.5 Ipca Laboratories Recent Development 11.11 Cipla 11.11.1 Cipla Company Details 11.11.2 Cipla Business Overview 11.11.3 Cipla Artemisinin Combination Therapy Introduction 11.11.4 Cipla Revenue in Artemisinin Combination Therapy Business (2016-2021) 11.11.5 Cipla Recent Development 11.12 Aspen Pharmacare Holdings 11.12.1 Aspen Pharmacare Holdings Company Details 11.12.2 Aspen Pharmacare Holdings Business Overview 11.12.3 Aspen Pharmacare Holdings Artemisinin Combination Therapy Introduction 11.12.4 Aspen Pharmacare Holdings Revenue in Artemisinin Combination Therapy Business (2016-2021) 11.12.5 Aspen Pharmacare Holdings Recent Development 11.13 Ajanta Pharma 11.13.1 Ajanta Pharma Company Details 11.13.2 Ajanta Pharma Business Overview 11.13.3 Ajanta Pharma Artemisinin Combination Therapy Introduction 11.13.4 Ajanta Pharma Revenue in Artemisinin Combination Therapy Business (2016-2021) 11.13.5 Ajanta Pharma Recent Development 11.14 Guilin Pharmaceuticals 11.14.1 Guilin Pharmaceuticals Company Details 11.14.2 Guilin Pharmaceuticals Business Overview 11.14.3 Guilin Pharmaceuticals Artemisinin Combination Therapy Introduction 11.14.4 Guilin Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2016-2021) 11.14.5 Guilin Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Artemisinin Combination Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Artemether+Lumefantrine Table 3. Key Players of Artesunate+Amodiaquine Table 4. Key Players of Dihydroartemisinin+Piperaquine Table 5. Key Players of Artesunate+Mefloquine Table 6. Key Players of Artesunate+Sulfadoxine-Pyrimethamine Table 7. Key Players of Pyronaridine-Artesunate Table 8. Key Players of Other Table 9. Global Artemisinin Combination Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Artemisinin Combination Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Artemisinin Combination Therapy Market Size by Regions (2016-2021) & (US$ Million) Table 12. Global Artemisinin Combination Therapy Market Share by Regions (2016-2021) Table 13. Global Artemisinin Combination Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 14. Global Artemisinin Combination Therapy Market Share by Regions (2022-2027) Table 15. Artemisinin Combination Therapy Market Trends Table 16. Artemisinin Combination Therapy Market Drivers Table 17. Artemisinin Combination Therapy Market Challenges Table 18. Artemisinin Combination Therapy Market Restraints Table 19. Global Artemisinin Combination Therapy Revenue by Players (2016-2021) & (US$ Million) Table 20. Global Artemisinin Combination Therapy Market Share by Players (2016-2021) Table 21. Global Top Artemisinin Combination Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artemisinin Combination Therapy as of 2020) Table 22. Ranking of Global Top Artemisinin Combination Therapy Companies by Revenue (US$ Million) in 2020 Table 23. Global 5 Largest Players Market Share by Artemisinin Combination Therapy Revenue (CR5 and HHI) & (2016-2021) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Artemisinin Combination Therapy Product Solution and Service Table 26. Date of Enter into Artemisinin Combination Therapy Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Artemisinin Combination Therapy Market Size by Type (2016-2021) (US$ Million) Table 29. Global Artemisinin Combination Therapy Revenue Market Share by Type (2016-2021) Table 30. Global Artemisinin Combination Therapy Forecasted Market Size by Type (2022-2027) (US$ Million) Table 31. Global Artemisinin Combination Therapy Revenue Market Share by Type (2022-2027) & (US$ Million) Table 32. Global Artemisinin Combination Therapy Market Size Share by Application (2016-2021) & (US$ Million) Table 33. Global Artemisinin Combination Therapy Revenue Market Share by Application (2016-2021) Table 34. Global Artemisinin Combination Therapy Forecasted Market Size by Application (2022-2027) (US$ Million) Table 35. Global Artemisinin Combination Therapy Revenue Market Share by Application (2022-2027) & (US$ Million) Table 36. North America Artemisinin Combination Therapy Market Size by Type (2016-2021) (US$ Million) Table 37. North America Artemisinin Combination Therapy Market Size by Type (2022-2027) & (US$ Million) Table 38. North America Artemisinin Combination Therapy Market Size by Application (2016-2021) (US$ Million) Table 39. North America Artemisinin Combination Therapy Market Size by Application (2022-2027) & (US$ Million) Table 40. North America Artemisinin Combination Therapy Market Size by Country (2016-2021) & (US$ Million) Table 41. North America Artemisinin Combination Therapy Market Size by Country (2022-2027) & (US$ Million) Table 42. Europe Artemisinin Combination Therapy Market Size by Type (2016-2021) (US$ Million) Table 43. Europe Artemisinin Combination Therapy Market Size by Type (2022-2027) & (US$ Million) Table 44. Europe Artemisinin Combination Therapy Market Size by Application (2016-2021) (US$ Million) Table 45. Europe Artemisinin Combination Therapy Market Size by Application (2022-2027) & (US$ Million) Table 46. Europe Artemisinin Combination Therapy Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe Artemisinin Combination Therapy Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific Artemisinin Combination Therapy Market Size by Type (2016-2021) (US$ Million) Table 49. Asia-Pacific Artemisinin Combination Therapy Market Size by Type (2022-2027) & (US$ Million) Table 50. Asia-Pacific Artemisinin Combination Therapy Market Size by Application (2016-2021) (US$ Million) Table 51. Asia-Pacific Artemisinin Combination Therapy Market Size by Application (2022-2027) & (US$ Million) Table 52. Asia-Pacific Artemisinin Combination Therapy Market Size by Region (2016-2021) & (US$ Million) Table 53. Asia-Pacific Artemisinin Combination Therapy Market Size by Region (2022-2027) & (US$ Million) Table 54. Latin America Artemisinin Combination Therapy Market Size by Type (2016-2021) (US$ Million) Table 55. Latin America Artemisinin Combination Therapy Market Size by Type (2022-2027) & (US$ Million) Table 56. Latin America Artemisinin Combination Therapy Market Size by Application (2016-2021) (US$ Million) Table 57. Latin America Artemisinin Combination Therapy Market Size by Application (2022-2027) & (US$ Million) Table 58. Latin America Artemisinin Combination Therapy Market Size by Country (2016-2021) & (US$ Million) Table 59. Latin America Artemisinin Combination Therapy Market Size by Country (2022-2027) & (US$ Million) Table 60. Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2016-2021) (US$ Million) Table 61. Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2022-2027) & (US$ Million) Table 62. Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2016-2021) (US$ Million) Table 63. Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2022-2027) & (US$ Million) Table 64. Middle East & Africa Artemisinin Combination Therapy Market Size by Country (2016-2021) & (US$ Million) Table 65. Middle East & Africa Artemisinin Combination Therapy Market Size by Country (2022-2027) & (US$ Million) Table 66. KPC Pharmaceuticals Company Details Table 67. KPC Pharmaceuticals Business Overview Table 68. KPC Pharmaceuticals Artemisinin Combination Therapy Product Table 69. KPC Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million) Table 70. KPC Pharmaceuticals Recent Development Table 71. Shanghai Fosun Pharmaceutical Industrial Development Company Details Table 72. Shanghai Fosun Pharmaceutical Industrial Development Business Overview Table 73. Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product Table 74. Shanghai Fosun Pharmaceutical Industrial Development Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million) Table 75. Shanghai Fosun Pharmaceutical Industrial Development Recent Development Table 76. Sanofi Company Details Table 77. Sanofi Business Overview Table 78. Sanofi Artemisinin Combination Therapy Product Table 79. Sanofi Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million) Table 80. Sanofi Recent Development Table 81. Desano Holdings Company Details Table 82. Desano Holdings Business Overview Table 83. Desano Holdings Artemisinin Combination Therapy Product Table 84. Desano Holdings Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million) Table 85. Desano Holdings Recent Development Table 86. Calyx Chemicals and Pharmaceuticals Company Details Table 87. Calyx Chemicals and Pharmaceuticals Business Overview Table 88. Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product Table 89. Calyx Chemicals and Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million) Table 90. Calyx Chemicals and Pharmaceuticals Recent Development Table 91. Mylan Company Details Table 92. Mylan Business Overview Table 93. Mylan Artemisinin Combination Therapy Product Table 94. Mylan Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million) Table 95. Mylan Recent Development Table 96. Novartis Company Details Table 97. Novartis Business Overview Table 98. Novartis Artemisinin Combination Therapy Product Table 99. Novartis Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million) Table 100. Novartis Recent Development Table 101. Denk Pharma Company Details Table 102. Denk Pharma Business Overview Table 103. Denk Pharma Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million) Table 104. Denk Pharma Recent Development Table 105. Hovid Berhad Company Details Table 106. Hovid Berhad Business Overview Table 107. Hovid Berhad Artemisinin Combination Therapy Product Table 108. Hovid Berhad Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million) Table 109. Hovid Berhad Recent Development Table 110. Ipca Laboratories Company Details Table 111. Ipca Laboratories Business Overview Table 112. Ipca Laboratories Artemisinin Combination Therapy Product Table 113. Ipca Laboratories Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million) Table 114. Ipca Laboratories Recent Development Table 115. Cipla Company Details Table 116. Cipla Business Overview Table 117. Cipla Artemisinin Combination Therapy Product Table 118. Cipla Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million) Table 119. Cipla Recent Development Table 120. Aspen Pharmacare Holdings Company Details Table 121. Aspen Pharmacare Holdings Business Overview Table 122. Aspen Pharmacare Holdings Artemisinin Combination Therapy Product Table 123. Aspen Pharmacare Holdings Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million) Table 124. Aspen Pharmacare Holdings Recent Development Table 125. Ajanta Pharma Company Details Table 126. Ajanta Pharma Business Overview Table 127. Ajanta Pharma Artemisinin Combination Therapy Product Table 128. Ajanta Pharma Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million) Table 129. Ajanta Pharma Recent Development Table 130. Guilin Pharmaceuticals Company Details Table 131. Guilin Pharmaceuticals Business Overview Table 132. Guilin Pharmaceuticals Artemisinin Combination Therapy Product Table 133. Guilin Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million) Table 134. Guilin Pharmaceuticals Recent Development Table 135. Research Programs/Design for This Report Table 136. Key Data Information from Secondary Sources Table 137. Key Data Information from Primary Sources List of Figures Figure 1. Global Artemisinin Combination Therapy Market Share by Type: 2020 VS 2027 Figure 2. Artemether+Lumefantrine Features Figure 3. Artesunate+Amodiaquine Features Figure 4. Dihydroartemisinin+Piperaquine Features Figure 5. Artesunate+Mefloquine Features Figure 6. Artesunate+Sulfadoxine-Pyrimethamine Features Figure 7. Pyronaridine-Artesunate Features Figure 8. Other Features Figure 9. Global Artemisinin Combination Therapy Market Share by Application: 2020 VS 2027 Figure 10. Hospital Case Studies Figure 11. Clinic Case Studies Figure 12. Other Case Studies Figure 13. Artemisinin Combination Therapy Report Years Considered Figure 14. Global Artemisinin Combination Therapy Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global Artemisinin Combination Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Artemisinin Combination Therapy Market Share by Regions: 2020 VS 2027 Figure 17. Global Artemisinin Combination Therapy Market Share by Regions (2022-2027) Figure 18. Global Artemisinin Combination Therapy Market Share by Players in 2020 Figure 19. Global Top Artemisinin Combination Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artemisinin Combination Therapy as of 2020 Figure 20. The Top 10 and 5 Players Market Share by Artemisinin Combination Therapy Revenue in 2020 Figure 21. Global Artemisinin Combination Therapy Revenue Market Share by Type (2016-2021) Figure 22. Global Artemisinin Combination Therapy Revenue Market Share by Type (2022-2027) Figure 23. North America Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America Artemisinin Combination Therapy Market Share by Type (2016-2027) Figure 25. North America Artemisinin Combination Therapy Market Share by Application (2016-2027) Figure 26. North America Artemisinin Combination Therapy Market Share by Country (2016-2027) Figure 27. United States Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Artemisinin Combination Therapy Market Share by Type (2016-2027) Figure 31. Europe Artemisinin Combination Therapy Market Share by Application (2016-2027) Figure 32. Europe Artemisinin Combination Therapy Market Share by Country (2016-2027) Figure 33. Germany Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Artemisinin Combination Therapy Market Share by Type (2016-2027) Figure 41. Asia-Pacific Artemisinin Combination Therapy Market Share by Application (2016-2027) Figure 42. Asia-Pacific Artemisinin Combination Therapy Market Share by Region (2016-2027) Figure 43. China Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Artemisinin Combination Therapy Market Share by Type (2016-2027) Figure 51. Latin America Artemisinin Combination Therapy Market Share by Application (2016-2027) Figure 52. Latin America Artemisinin Combination Therapy Market Share by Country (2016-2027) Figure 53. Mexico Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Artemisinin Combination Therapy Market Share by Type (2016-2027) Figure 57. Middle East & Africa Artemisinin Combination Therapy Market Share by Application (2016-2027) Figure 58. Middle East & Africa Artemisinin Combination Therapy Market Share by Country (2016-2027) Figure 59. Turkey Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. KPC Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021) Figure 63. Shanghai Fosun Pharmaceutical Industrial Development Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021) Figure 64. Sanofi Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021) Figure 65. Desano Holdings Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021) Figure 66. Calyx Chemicals and Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021) Figure 67. Mylan Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021) Figure 68. Novartis Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021) Figure 69. Denk Pharma Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021) Figure 70. Hovid Berhad Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021) Figure 71. Ipca Laboratories Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021) Figure 72. Cipla Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021) Figure 73. Aspen Pharmacare Holdings Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021) Figure 74. Ajanta Pharma Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021) Figure 75. Guilin Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021) Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

KPC Pharmaceuticals Shanghai Fosun Pharmaceutical Industrial Development Sanofi Desano Holdings Calyx Chemicals and Pharmaceuticals Mylan Novartis Denk Pharma Hovid Berhad Ipca Laboratories Cipla Aspen Pharmacare Holdings Ajanta Pharma Guilin Pharmaceuticals